Trial Profile
Phase I Study of ALT-801 in Patients With Progressive Metastatic Malignancies.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs ALT 801 (Primary)
- Indications Cancer
- Focus Adverse reactions
- 03 Nov 2009 Planned number of patients changed from 46 to 26 as reported by ClinicalTrials.gov.
- 03 Nov 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
- 03 Nov 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.